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Summary
BACKGROUND: MD-PhD programmes throughout the
world provide a platform for medical trainees to commit to
a physician-scientist career, qualifying with both a med-
ical degree (MD or equivalent) and Doctor of Philosophy
(PhD). However, there are limited studies assessing the
characteristics of MD-PhD programmes in Europe and the
outcomes of MD-PhD students and graduates.
PURPOSE: This study aims at a first country-wise ex-
ploration of characteristics, opinions, and academic out-
comes of MD-PhD students and graduates in Europe.
METHODS: Two questionnaires were developed to as-
sess the demographics, MD-PhD programme characteris-
tics, opinions, future career paths and academic outcomes
of European MD-PhD students and graduates. An online
survey of 278 MD-PhD students and 121 MD-PhD grad-
uates from nine and six European countries, respectively,
was completed between April 2016 and December 2017.
The country-wise categorical responses were then com-
pared through chi-square analysis followed by multiple lo-
gistic regression.
RESULTS: Responses from 266 MD-PhD students and
117 MD-PhD graduates were considered valid. Significant
country-wise differences (p <0.05) were observed for age
group, resident status, clinical time allocation, duration of
studies, sources of funding, publications, average impact
factor of the journals in which the research was published,
satisfaction with the duration of MD-PhD studies and fu-
ture career choices of MD-PhD students. Responses re-
lated to self-perception about clinical and research com-
petence and challenges faced during MD-PhD training did
not show a significant country-wise difference.
CONCLUSION: The MD-PhD workforce in Europe is high-
ly diverse in their demographics, programme characteris-
tics and career paths but does not differ in opinions related
to the challenges faced. The results of this study may be
helpful for implementation and improvement of MD-PhD
programmes.
Keywords: MD-PhD, physician-scientist, translational,
outcome
Introduction
A number of medical faculties around the world implement
programmes that allow the combination of medical studies
with a Doctor of Philosophy (PhD). These dual degree pro-
grammes, generally termed as MD-PhD, lead to a unique
career path and development of physician-scientists.
Physician-scientists are health professionals who have un-
dergone substantial training in research, typically a PhD, in
addition to the conventional clinical training. The aim of
this training is to prepare the medical community for the
increasing complexity of academic medicine and to accel-
erate the translation of basic research into clinical thera-
pies. Such training programmes are most suited to medical
students and physicians who wish to dedicate a substantial
amount of effort to academic research [1].
The origin of physician-scientist education is in the USA,
where the first organised MD-PhD programme was estab-
lished in 1956. Currently, around 90 such programmes ex-
ist in the US [1]. However, there have been recent con-
cerns about a steady decline in physicians opting for career
paths with a primary focus on research [2, 3]. As a result,
concerted efforts are being made to ascertain the opinions
and academic outcomes of MD-PhD students and gradu-
ates to optimise the structure of existing and future MD-
PhD programmes in the US [1, 4–15]. A recent such study
(n = 6876 MD-PhD alumni) by the Association of Amer-
ican Medical Colleges identified that the number of MD-
PhD graduates in the US remains less than desired and they
comprise a very small proportion of medical school grad-
uates [4]. Nevertheless, MDPhDs are rendering a remark-
able service to biomedical research and academic medicine
and roughly three quarters of the MD-PhD graduates stay
engaged in long-term research [4, 16].
Owing to the very pluralistic higher education system in
Europe, MD-PhD/physician-scientist programmes in Eu-
rope are highly diverse in their curricular framework. First,
the terminology for physician-scientist education is not
consistent in Europe, with such programmes being labelled
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as MD-PhD in a majority of countries, such as in Switzer-
land, France and the Netherlands; MB-PhD in the United
Kingdom (UK); and Dr. med. Dr. rer. nat. in Germany. In
the context of this study, an MD-PhD graduate is defined
as someone who has successfully obtained both the med-
ical diploma and the PhD degree. Second, the programmes
are extremely variable with regards to the timing of PhD
studies. In France and the UK, the PhD thesis is integrated
as a fulltime research period during medical school train-
ing. In the Netherlands, students alternate between peri-
ods of clinical and research placements during medical
school. In Germany and Switzerland, the structures are in-
consistent between institutions with some programmes in-
corporating PhD studies parallel to medical school stud-
ies, whereas others require a medical degree for enrolment
of students to 80-100% research-commitment for the PhD
(fig. 1).
This diversity of MD-PhD curricula in Europe allows a
unique opportunity to study the effects of different MD-
PhD training frameworks on the attitudes and challenges of
MD-PhD students and graduates. To the best of our knowl-
edge, the only assessments of MD-PhD students and grad-
uates in Europe have been on students from single pro-
grammes or countries [17–20]. The European MD-PhD
Association (EMPA), officially formed in 2015 as a net-
working platform of physician-scientists across Europe, is
Figure 1: Representative structures of MD-PhD programmes in
five European countries. Each block represents one year. Blue
blocks represent research time; Orange blocks represent medical/
clinical education. Both activities can also be done in parallel or
consecutively. In the UK, MD-PhD students continue their clinical
training throughout the research period. FY = foundation year;
AMC = Academic Medical Centre
uniquely placed to comprehensively assess the character-
istics and outcomes of MD-PhD students and graduates in
Europe because of its representation in different European
countries [21]. The aim of the current study was to ex-
plore the demographics, career paths, and opinions regard-
ing satisfaction and challenges of MD-PhD students and
graduates from different European countries. Additionally,
we outline the MD-PhD programme structures of the ma-
jor countries where the study was performed. We note that
differences in structure may influence the demographics
and characteristics of the MD-PhD students and graduates.
The results of this study may help as a direct feedback to
the MD-PhD programme coordinators and policy makers
to optimise MD-PhD curricula suitable to the preferences
and challenges of the MD-PhD workforce, thus ensuring a
greater commitment to stay engaged in a physician-scien-
tist career. Finally, by giving insights in the structure and
importance of MD-PhD programmes in Europe, this study
could promote a better dissemination of such programmes.
Methods
Study design
This study comprised a cross-sectional survey-based as-
sessment of MD-PhD students and graduates from nine
European countries overall. The anonymous survey was
conducted amongst attendees of MD-PhD programmes:
those who were currently enrolled in MD-PhD pro-
grammes (students) and those who had already graduated
(graduates) at the time of completing the survey (April
2016 to December 2017). Students and graduates were in-
vited to fill in the appropriate questionnaire (uploaded on a
Google survey platform) based on their status. After initial
contact, two more reminders were sent 6 and 12 months
after the initial approach. The anonymity of participants
was maintained throughout the process of data sampling
and analysis. For countries with fewer than 10 responses,
where the anonymity of the respondents could be compro-
mised, the responses were pooled together in an arbitrary
category “others”.
Questionnaire development
The questionnaires were developed based on previously
published studies [14, 18]. They included questions that as-
sessed training characteristics, opinions, and outcomes of
MD-PhD students and graduates and were adjusted from
original resources (questionnaires are available in appen-
dices 1 and 2). The feasibility of the surveys was tested
through a pilot study on five MD-PhD students and grad-
uates each from Switzerland and the Netherlands prior to
the full data collection.
Two separate questionnaires were used for MD-PhD stu-
dents and graduates. The questionnaire for students com-
prised closed-ended questions, which collected informa-
tion regarding their demographics, training characteristics,
current position and activity, career path, career goals,
opinions about the utility of MD-PhD studies, publications,
and their satisfaction with their MD-PhD studies. The
questionnaire for graduates included questions related to
the academic standing of MD-PhD graduates and their
opinions related to the obstacles they have faced in pursu-
ing a physician-scientist career, besides demographics. In
addition, there was an opportunity for MD-PhD students
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and graduates to give comments at the end of each survey.
The opinion questions employed a Likert-like scale and
showed a consistent clustering of responses, hence, pre-
cluding the need for a factor analysis.
Ethical considerations
Informed consent was obtained from each participant to
allow the use of their answers for anonymous recording,
analysis and publication. The confidentiality of the partic-
ipants was maintained through all phases of the study. An
institutional review board (IRB) approval was not obtained
for the study as the study was conducted solely from the
EMPA platform.
Data collection
Using a nonrandomised referral sampling (snow-ball sam-
pling) method, study participants were contacted by mem-
bers of the EMPA Executive Board and EMPA Board of
Representatives, either personally or via institutional com-
munication channels. For Switzerland and the Netherlands,
MD-PhD student and graduate mailing lists were acquired
by EMPA. In France, the French National MD/PharmD-
PhD Association (Association Médecine/Pharmacie Sci-
ences) relayed the survey to its members. In the UK, uni-
versities with official MD-PhD programmes were
contacted to ask if surveys could be circulated to their MD-
PhD students and graduates, inviting them to participate.
For the remaining countries, social networks and person-
al contacts were used to recruit participants. Sampling did
not follow a balanced European or country-wise distribu-
tion since the number of recipients was not known. Wher-
ever possible, multiple institutes within a country were ap-
proached to participate. However, as a result of the referral
sampling method, the exact affiliations of the participants
is not clear in all the cases. Furthermore, confidentiali-
ty reasons precluded us from having access to participant
lists of individual MD-PhD programmes. Thus, we were
not able to calculate the response rate. A total of 278 sur-
veys were completed by current MD-PhD students, out of
whom 12 participants were excluded because of ambigu-
ous or incomplete answers. Similarly, a total of 121 sur-
veys were completed by MD-PhD graduates and 4 partici-
pants were excluded because of ambiguous answers. Only
fully filled questionnaires were considered valid and in-
cluded in the final analysis.
Statistical analysis
Statistical analyses were performed using IBM SPSS Sta-
tistics version 25 [22]. Categorical variables were com-
pared between MD-PhD students and graduates from dif-
ferent countries using the chi-square test. For questions
assessing the future career choices of MD-PhD students,
predictors with significant p-values on univariate analyses
were further assessed through multivariate logistic regres-
sion to adjust for the effect of confounders. The con-
founders were individual predictors that showed signifi-
cant differences (p <0.05) in univariate analysis and were
used as reference points in multivariate modelling. Signif-
icant predictors were expressed by odds ratios (ORs) us-
ing specified reference categories. All results with a p-val-
ue less than 0.05 were considered significant.
Results
Structures of MD-PhD programmes
To have a clear overview of the differences in the structural
frameworks of MD-PhD programmes in the countries as-
sessed, the MD-PhD programme structures were verified
through reliable resources (referenced articles and official
websites) [18, 23–26]. As expected, country-wise differ-
ences are prominent in terms of the timings of MD-PhD
candidate selection and periods of research during the MD-
PhD studies in the most-represented countries. Further-
more, the programme structures are not always uniform
within the same country (fig. 1).
Demographics of MD-PhD students
The valid responses (n = 266) were from France (n =
93), Switzerland (n = 77), the Netherlands (n = 45), UK
(n = 23), Germany (n = 15), Italy (n = 8), Portugal (n
= 3), Georgia (n = 1) and Norway (n = 1). Responses
from the countries with fewer than 10 participants (Italy,
Portugal, Georgia, Norway) were grouped together in the
“others” category (n = 13). The gender distribution did
not differ significantly (p >0.05) between different coun-
tries. Overall, 45 MD-PhD students were not citizens of
the countries of their MD-PhD training. Eighteen MD-PhD
students had non-European citizenship, including five par-
ticipants from China, three from Morocco, two from Pak-
istan, and one each from Bangladesh, Brazil, Egypt, In-
donesia, Iran, Mauritius, Mexico, Saudi Arabia, and South
Korea. Germany (40%) and Switzerland (31.1%) had the
highest proportion of foreign MD-PhD students. The ma-
jority of MD-PhD students from France (62.4%) and the
UK (52.2%) were in the age group of 20–24 years, whereas
the majority of students from Switzerland (64.9%) and the
Netherlands (60.0%) were in the 25–29 years old category
(table 1).
Significant differences (p <0.05) between countries were
observed in the MD-PhD curricular track followed by MD-
PhD students. A majority of MD-PhD students were med-
ical students in France (83.9%), Germany (60.0%), the
Netherlands (66.7%) and the UK (100.0%) compared with
Switzerland where the majority (77.9%) of MD-PhD stu-
dents were already medical graduates.
Similarly, there was diversity between European countries
regarding the clinical time during MD-PhD studies, with
a vast majority of MD-PhD students in France, Germany,
Switzerland and the UK having less than 20% time allo-
cated to clinics. Further, the duration of MD-PhD studies
was significantly shorter in the Netherlands (60% less than
3 years) and the Netherlands was unique in terms of having
a vast majority (93.3%) of their MD-PhD students being
funded through MD-PhD scholarships (table 1).
Attitudes and academic outcomes of MD-PhD students
A significant country-wise difference (p <0.05) was ob-
served between MD-PhD students in terms of peer-re-
viewed publications that they had published or expected
to publish during their MD-PhD studies, with the Nether-
lands being the only country where a majority of students
(66.7%) expected to publish more than five articles.
When queried about the utility of MD-PhD studies, MD-
PhD students from all countries agreed that MD-PhDs are
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not better than non-clinician graduates with PhDs in terms
of their competence as researchers. Similarly, a majority of
MD-PhD students, irrespective of the country, were of the
opinion that MD-PhDs are not better clinicians than MDs
without PhDs. However, with regards to satisfaction with
the duration of studies, there was a country-wise difference
as a substantial proportion (31.1%) of the MD-PhD stu-
dents from the Netherlands found it to be too short (table
2).
Determinants of future career choices of MD-PhD stu-
dents
To ascertain which factors influence the future career
choices of MD-PhD students, a multivariate logistic re-
gression model was built including all factors queried,
which turned out to be significantly different (p <0.05)
among students from different countries. These factors in-
cluded: age group, resident status, clinical time during
MD-PhD studies, duration of MD-PhD studies, provision
of funding for MD-PhD by the host laboratory or through
an MD-PhD scholarship, publications during MD-PhD
studies, average impact factor of the journals in which stu-
dents published in or aimed to publish in, satisfaction with
the duration of MD-PhD studies and the importance of
different factors when deciding on a future career. Based
on the model, a strong preference (OR 8.28, 95% confi-
dence interval [CI] 2.09–32.79) for not doing basic sci-
ence research was found among MD-PhD students from
the Netherlands. A similar preference for not doing basic
science research was also observed for MD-PhD students
who had not published or expected to publish during their
studies (OR 6.94, 95% CI 1.31–36.81). Similarly, not per-
forming clinical duties during MD-PhD studies was asso-
ciated with a lack of interest in doing clinical research (OR
2.11, 95% CI 1.12–3.99) or considering a 100% clinical
career (OR 0.01, 95% CI 0.00–0.23) in the future. On the
contrary, students who did not consider opportunities for
patient care or financial security as important factors in de-
ciding their future showed an inclination towards a 100%
research career (table 3).
Demographics, outcomes and opinions of MD-PhD
graduates
The valid responses (n = 117) were from graduates who
completed MD-PhD programmes in six different European
countries: Switzerland (n = 54), the Netherlands (n = 45),
France (n = 7), the UK (n = 6), Germany (n = 3) and Ro-
mania (n = 2). Responses from countries with fewer than
10 responses were grouped together as the “other” catego-
ry (n = 18). A significantly higher proportion (66.7%) of
females were present in the group of MD-PhD graduates
from the Netherlands. A majority (60%) of the MD-PhD
graduates from the Netherlands were engaged in clinical
research, compared with the graduates from Switzerland
who were involved in basic science or translational re-
search (55.6%). The graduates from these countries also
differed in terms of publication outcomes after their MD-
PhD studies: whereas the majority (75.6%) of graduates
from the Netherlands did not publish after their MD-PhD,
the majority of graduates from Switzerland reported either
between one and five (40.7%) or six or more (35.2%)
publications (table 4). It is noteworthy that, despite these
differences, MD-PhD graduates from different countries
were in consensus when asked about major obstacles they
Table 1: Demographic and curricular details of current MD-PhD students according to the country of training. Data are percentages of MD-PhD students.
France
(n = 93)
Germany
(n = 15)
Switzerland
(n = 77)
The
Netherlands
(n = 45)
UK
(n = 23)
Others
(n = 13)
Total
(n = 266)
p-value
(χ2)
Gender (%) Females 44.1 46.7 35.1 53.3 21.7 46.2 41.4 ns
Males 55.9 53.3 64.9 46.7 78.3 53.8 58.6
Resident status
(%)
Foreigners 7.5 40.0 31.2 2.2 17.4 23.0 20.4 ***
Natives 92.5 60.0 68.8 97.8 82.6 77.0 79.6
Age group (%) <24 68.9 33.3 3.9 33.3 52.2 46.2 39.5 ***
25–29 18.3 26.7 64.9 60.0 43.5 46.2 42.9
>30 12.8 40.0 31.2 6.7 4.3 7.6 17.6
Current status (%) Medical student 83.9 66.7 20.8 66.7 100.0 100.0 63.2 ***
Medical graduate 9.7 33.3 77.9 33.3 – – 34.2
Other† 6.4 – 1.3 - – – 2.6
Clinical time dur-
ing MD-PhD stud-
ies (%)
None 32.3 60.0 41.6 8.9 43.5 23.1 33.1 ***
<20% 25.8 26.7 50.6 42.2 43.5 23.1 37.2
20–39% 8.6 6.7 6.5 1.1 – 17.4 8.8
40–59% 11.8 – 1.3 31.1 – 15.4 10.5
≥60% 21.5 6.6 – 6.7 13 4.2 10.5
Duration of MD-
PhD studies (%)
<3 years 7.5 20.0 3.9 60.0 – – 15.0 ***
3–3.5 years 23.7 46.7 70.1 11.1 43.5 69.2 40.2
4–4.5 years 11.8 20.0 24.7 24.4 4.3 - 16.9
≥5 years 57.0 13.3 1.3 4.5 52.2 31.8 27.9
Possibility of train-
ing in a foreign
country during
MD-PhD (%)
Yes 31.2 26.7 27.3 31.1 21.7 61.5 30.5 ns
No 68.8 73.3 73.7 68.9 78.3 38.5 69.5
Funding for MD-
PhD provided by
(%):‡
Host laboratory 49.5 53.3 63.6 8.9 43.5 43.5 45.5 ***
MD-PhD scholar-
ship
40.1 53.3 37.7 93.3 56.5 69.2 51.9
† Students doing a PhD in addition to a degree in veterinary or dental medicine; ‡ other sources of funding are not shown. * p <0.05, **p <0.01, ***p <0.001, ns = non-significant
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have faced in pursuing a physician-scientist career. Ap-
proximately half of the MD-PhD graduates across different
countries identified lack of opportunity (range
42.6–61.1%), lack of funding (range 42.6–66.7%) and lack
of work-personal life balance (range 38.9–53.7%) as the
major challenges. However, the majority of MD-PhD grad-
uates agreed that not finding a position in the desired loca-
tion, discrimination or under-compensation were not major
obstacles in this regard (table 5).
Discussion
This study outlines the structure of MD-PhD programmes
in six countries in Europe, highlighting differences in their
timing, duration and curricular framework. Concurrently,
a survey of European MD-PhD students and graduates re-
veals significant country-wise differences in terms of the
type of research performed and future career choices but
no differences in terms of the challenges faced during the
training.
The importance of physician-scientist education is increas-
ingly emphasised in the scientific community to bridge the
gap between the laboratory bench and the patient bedside.
A number of world-renowned universities have now in-
Table 2: Academic outcomes and attitudes of current MD-PhD students according to the country of training. Data are percentages of MD-PhD students.
France
(n = 93)
Germany
(n = 15)
Switzerland
(n = 77)
The Netherlands
(n = 45)
UK
(n = 23)
Others
(n = 13)
Total
(n = 266)
p-value
(χ2)
Publications and/or
expected publica-
tions during MD-PhD
studies (%)
<2 44.1 46.7 36.4 8.9 43.5 76.9 37.2 ***
3–4 31.2 20.0 41.6 24.4 21.7 15.3 31.2
≥5 24.7 33.3 22.0 66.7 34.8 7.8 31.6
Average impact fac-
tor of the journals
(%)
<5 20.4 33.3 48.1 51.2 26.1 30.8 35.3 ***
≥5 17.2 20.0 14.3 37.7 21.7 7.7 19.9
N/A, would not like
to disclose
62.4 46.7 37.6 11.1 52.2 61.5 44.8
Do you think MD-
PhDs are better re-
searchers than
PhDs†? (%)
Yes 17.2 20.0 15.6 13.3 13.0 23.3 18.5 ns
No 82.8 80.0 84.4 86.7 87.0 76.7 81.5
Do you think MD-
PhDs are better re-
searchers than
MDs‡? (%)
Yes 78.5 80.0 87.0 80.0 78.3 53.8 80.1 ns
No 21.5 20.0 13.0 20.0 21.7 46.2 19.9
Do you think MD-
PhDs are better clin-
icians than MDs?
(%)
Yes 29.0 6.7 18.2 26.7 17.4 30.8 23.3 ns
No 71.0 93.3 81.8 73.3 82.6 69.2 76.7
Are you satisfied
with the duration of
your MD-PhD? (%)
Just right 73.1 63.6 72.7 66.7 87.0 76.9 72.9 ***
Too little 4.3 13.3 3.9 31.1 13.0 23.1 10.9
Too much 22.6 23.1 23.4 2.2 – – 16.2
An important factor
in deciding your fu-
ture career path
would be:§
Opportunity for re-
search (%)
83.9 80.0 77.9 68.9 87.0 76.9 79.3 ns
Opportunity for pa-
tient care (%)
59.1 53.3 50.6 88.9 52.2 61.5 60.9 ***
Financial security
(%)
32.2 60.0 27.2 26.7 43.5 23.0 32.0 ns
Work-personal life
balance (%)
47.3 53.3 44.2 68.9 60.1 69.2 51.1 ns
† PhDs = non-clinician graduates with PhDs; ‡ = clinicians without a PhD; § Data on other potentially important factors in selecting future careers are not shown: opportunities for
teaching, community service, travel or international work, ability to balance work and personal life, and prestige * p <0.05, ** p <0.01, *** p <0.001, ns = non-significant
Table 3: Significant determinants of future career choices of current MD-PhD students established through multiple logistic regression. Independent associations of variables
that are different in MD-PhDs from different countries are assessed against questions related to their future career paths.
Future career path Potential predictors Odds ratio p-value (95% confidence in-
terval)
Will not do basic research in future MD-PhD training in the Netherlands compared to
other countries
8.28 * (2.09–32.79)
Zero articles during MD-PhD studies compared to
having one or more publications
6.94 * (1.31–36.81)
Will not do clinical research in future No clinical duties during MD-PhD studies compared
to 20% or more time allocated to clinical duties
2.11 * (1.12–3.99)
Allocation for research/clinical time in an ide-
al career†
100% clinical No clinical duties during MD-PhD studies compared
to 20% or more time allocated to clinical duties
0.01 *** (0.00–0.23)
100% research Opportunity for patient care is not an important fac-
tor for deciding future career
9.63 ** (1.93–47.95)
Financial security is not an important factor for de-
ciding future career
6.56 * (1.11–38.92)
75% clinical, 25% re-
search
MD-PhD training in the Netherlands compared to
other countries
8.49 * (1.09–66.26)
† No significant factors were identified related to “25% clinical, 75% research” or “50% clinical, 50% research” options. * p <0.05, ** p <0.01, *** p <0.001
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tegrated clinical medicine into their biology programmes
[27]. Moreover, MD-PhD programmes are now successful-
ly in place around the world, including in Asia and Aus-
tralia [1, 21, 28–30]. With the rapid expansion of such
programmes in different European countries [18–20], it is
important that the structure of MD-PhD training is dynam-
ically adapted to alleviate the challenges for current MD-
PhD students and to attract the best talents among medical
students for MD-PhD training. The heterogeneity of MD-
PhD curricula in Europe allows a unique opportunity to
ascertain the effects of these inter-curricular variations on
the programme characteristics, career choices and academ-
ic outcomes of MD-PhDs. The results of this study suggest
that variation in the curricular structure does indeed influ-
ence the career choices and academic outcomes of MD-
PhD students in different European countries.
Major differences were observed between different coun-
tries among MD-PhD students, as well as, MD-PhD grad-
uates. These included age group, clinical time during MD-
PhD studies and engagement of graduates with basic and
clinical research, and could be explained by the curricular
differences. However, it is unknown whether students in-
terpreted clinical time during their MD-PhD studies as
clinical time during the PhD or throughout the MD-PhD
training. Reasonably, the majority of graduates from the
Netherlands, where MD-PhD studies have a clear focus
on clinical research, are also more engaged in clinical re-
search. For instance, the MD-PhD curriculum in the med-
ical university of Groningen, which had a substantial rep-
resentation in the responses from the Netherlands, has
some unique characteristics. It is an accelerated MD-PhD
programme with a usual allocation of 2 years as dedicated
research time. It is important to consider that this provision
also influences the type of research performed, with a pref-
erence for clinically oriented research. Furthermore, the
students from the Netherlands considered an opportunity
for patient care as an important factor in deciding their fu-
ture career path, highlighting a greater emphasis on clinical
care in the Dutch MD-PhD curriculum.
Interestingly, across the different European countries, the
majority of MD-PhD students believed that their research
competence is not better than non-clinician graduates hold-
ing a PhD and that their clinical acumen and skills are
not better than clinicians without a PhD. To the best of
our knowledge, there is no clear evidence that the quality
of academic or clinical performance differs between MD-
PhDs and PhDs and MDs.
A comparison of our study with previous similar studies
indicates some disparities in the opinions of MD-PhD stu-
dents and graduates. Whereas MD-PhD graduates in our
Table 4: Demographic and academic outcomes of MD-PhD graduates according to the country of training. Data are percentages of MD-PhD graduates.
Switzerland
(n = 54)
The Netherlands
(n = 45)
Others
(n = 18)
Total
(n = 117)
p value
(χ2)
Gender (%) Females 33.3 66.7 33.3 46.2 **
Males 66.7 33.3 66.7 53.8
Resident status (%) Foreigners 18.5 6.7 28.6 14.5 ns
Natives 81.5 93.3 71.4 85.5
Age group (%) <30 7.4 66.7 22.2 32.5 **
≥30 92.6 33.3 77.8 67.5
Duration of MD-PhD studies (%) ≤3 years 22.2 40.0 22.2 29.1 **
4 years 68.5 33.3 44.4 51.3
≥5 years 9.3 26.7 33.4 19.6
Nature of current research (%) Basic science or translational 55.6 28.9 61.1 46.2 *
Clinical 25.9 60.0 16.7 36.8
Public health / policy making / not
doing research
18.5 11.1 22.9 17.0
Publications during MD-PhD
studies (%)
<2 24.1 51.1 38.9 36.8 *
3–4 48.1 11.1 33.3 31.6
≥5 27.8 37.8 27.8 31.6
Publications after MD-PhD stud-
ies (%)
None 24.1 75.6 22.2 43.6 **
1–5 40.7 22.2 38.9 33.3
≥6 35.2 2.2 38.9 23.1
* p <0.05, ** p <0.01, *** p <0.001, ns = non-significant
Table 5: Challenges faced by MD-PhD graduates according to the country of training. Percentages of MD-PhD graduates who considered each factor to be an obstacle in pur-
suing a physician-scientist career are shown.
A major obstacle in pursuing a physician-scientist career
has
been: (%)
Switzerland
(n = 54)
The Netherlands
(n = 45)
Others
(n = 18)
Total
(n = 117)
p-value
(χ2)
Lack of opportunity/funding 42.6 66.7 61.1 44.4 ns
Not finding position in the desired location 13.0 31.1 27.8 22.2 ns
Lack of mentoring 46.3 33.3 33.3 39.3 ns
Under-compensation 20.4 20.0 38.9 23.1 ns
Discrimination against your gender / ethnicity / sexual orienta-
tion / any other bias
7.4 0 11.1 5.1 ns
Work-personal life balance 53.7 40.0 38.9 46.2 ns
Unsatisfactory professional advancement 44.4 35.6 27.8 38.5 ns
ns = non-significant
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study identified lack of opportunity, funding and work-per-
sonal life balance as major obstacles in pursuing a physi-
cian-scientist career, a previous study from Switzerland in
2009 had identified lack of mentoring as the major ob-
stacle in combining a physician-scientist career amongst
MD-PhD students and graduates [18]. However, this issue
seems to have been addressed, as only one third of the
Swiss MD-PhD graduates identified lack of mentoring as
a challenge in the current study. Furthermore, while the
US physician-scientist workforce has in the past consid-
ered lower salary as a critical problem [1], only 23% of Eu-
ropean MD-PhD graduates identified it as a challenge in
our study. However, the range of responses here is broad
(20% in Switzerland to 39% in “others”), which raises the
possibility that this could be a challenge in some countries
that may be underrepresented in the current study. In accor-
dance with our findings, an Australian study also identified
time and work-personal life balance as key problems faced
by MD-PhD students [31].
The current study has several strengths. First, there are lim-
ited number of studies exploring the MD-PhD programme
characteristics, opinions, career choices and outcomes of
MD-PhD students and graduates. No such studies exist for
some countries included in our analysis. Hence, results of
this survey could serve as critical feedback to universities
running MD-PhD programmes in these countries. Second,
the diversity of MD-PhD programmes in Europe offers an
opportunity to study the influence of diverse curricula on
the opinions, career choices and outcomes of MD-PhD stu-
dents and graduates. Third, a parallel analysis of students
and graduates provides some insight, albeit limited, into
how the opinions of MD-PhDs are shaped during and after
their training, although this warrants a prospective investi-
gation.
However, limitations of the study must be considered when
interpreting the results. First, owing to the sampling strat-
egy, a response bias cannot be eliminated. For example,
there was an over-representation of the responses from
the University of Groningen among the students from the
Netherlands compared with the students from other uni-
versities. Second, the number of participants from different
countries was not equal. However, use of nonparametric
tests (chi-square) precludes any major bias resulting from
these differences. Third, there is a disparity in the country-
wise representation of MD-PhD students and graduates,
and it is recognised that not all European MD-PhD stu-
dents and graduates completed the surveys because, for ex-
ample, of contact details being unavailable or out of date.
Fourth, as a result of curricular differences, students’ and
graduates’ interpretation of the survey may have been dif-
ferent. Fifth, the responses of the MD-PhD students are
from nine different countries, whereas the responses of the
graduates are from six different countries. It would have
been ideal to have a consistent country-wise representation
for students and graduates, but systematic access to MD-
PhD graduates was not achieved. Finally, the sample size
for the graduates was limited, warranting caution in gener-
alising the results of this study.
In conclusion, this first survey of MD-PhD students and
graduates across Europe shows strong effects of curricular
frameworks on opinions, career choices and outcomes of
MD-PhD students. Surprisingly, despite a huge diversity
in MD-PhD training, perceptions about their clinical and
research competence and challenges faced by MD-PhDs
are similar. This up-to-date summary of European physi-
cian-scientists’ early career paths can serve as an invalu-
able source for medical universities when implementing
new MD-PhD programmes or optimising current ones.
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Appendix 1
Questionnaire for students
Appendix 2
Questionnaire for graduates
The appendices are available in separate files at
https://smw.ch/article/doi/smw.2020.20205.
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